About DePuy Synthes

  • Contact Us
  • Healthcare Providers

Search DePuy Synthes

search

News and Press

DEPUY SYNTHES CMF LAUNCHES NEW MATRIXRIB MIPO INSTRUMENTATION FOR LESS INVASIVE SURGICAL FIXATION OF RIB FRACTURES

Solothurn, Switzerland – 4th December 2013 – DePuy Synthes CMF, a leader in skeletal and soft tissue repair and reconstruction, announce the launch of new instrumentation that enable less invasive surgical fixation and stabilization of rib fractures with the company's MatrixRIB™ System of precontoured, low-profile titanium plates, locking screws and intramedullary splints.

 
MatrixRIBTM Minimally Invasive Plate Osteosynthesis (MIPO) instrumentation was designed to provide surgeons with less invasive access, through small incisions, to rib fractures including difficult to reach sub-scapula rib fractures. The new instruments include a Trocar, Threaded Reduction Tool (TRT) with self-drilling tip, and 90° screwdriver with drilling capability. 
 
"Surgical fixation and stabilization of painful rib fractures is a growing procedure and the introduction of new MIPO instrumentation should help make it an even more attractive option for both surgeons and patients," said Karl Zerderfeldt, Group Marketing Manager, DePuy Synthes CMF.  
Rib fractures are associated with respiratory complications, prolonged hospitalization, prolonged pain, long-term disability and mortality.1
 
The potential benefits of surgical stabilization (osteosynthesis) of severe rib fractures over non-surgical treatments include reduced duration of mechanical ventilation support, shortened ICU stays and hospitalization, better secretion management through efficient cough, and minimized chest wall deformities resulting from trauma.2,3
 
More than 5,000 patients worldwide have received MatrixRIB implants since the System was launched in 2009. The MatrixRIB System is indicated for the fixation and stabilization of rib fractures, fusions and osteotomies of normal and osteoporotic bone.*
MatrixRIBTM is the only rib fixation system that is approved by the AO Foundation, an independent medically guided nonprofit organization led by an international group of surgeons specialized in the treatment of trauma and disorders of the musculoskeletal system. For more information, visit www.aofoundation.org.
 
About DePuy Synthes CMF
DePuy Synthes CMF is a global leader in medical devices, offering a comprehensive portfolio of implant systems for surgeons to treat patients who have sustained conditions affecting the face, head, neck and thorax, including solutions for craniomaxillofacial, sternum and rib fixation. DePuy Synthes CMF is part of the DePuy Synthes Companies of Johnson & Johnson, the largest provider of orthopaedic and neurological solutions in the world. For more information, visit www.depuysynthes.com.
 
*Please refer to the MatrixRIB technique guide and package insert for full indications, contraindications, instructions for use, warnings and/or precautions.
 

CONTACTS:

Jennifer Skilbeck
(+44) 1133877862
jskilbec@its.jnj.com

 
References:
1. Nirula R, Mayberry JC.:"Rib fracture fixation: controversies and technical challenges." The American Surgeon. 2010 Aug;76(8):793-802.
2. Ahmed Z, Mohyuddin Z: “Management of flail chest injury: internal fixation versus endotracheal intubation and ventilation.”, J Thorac Cardiovasc Surg. 1995 Dec;110(6):1676-80 
3. Tanaka H, Yukioka T, Yamaguti Y, Shimizu S, Goto H, Matsuda H, Shimazaki S: “Surgical stabilization of internal pneumatic stabilization. A prospective randomized study of management of severe flail chest patients.”, J Trauma. 2002;52(4):727-32; discussion 32
V1013A
Filed under: Tagged:
Results per page: 
10
Back To Top